Impact of HER2 codon 655 polymorphism and expression of HER2 and HER3 in non small cell lung cancer patients.

about

Impact of HER2 codon 655 polymorphism and expression of HER2 and HER3 in non small cell lung cancer patients.

Item

http://www.wikidata.org/entity/Q50877452

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Impact of HER2 codon 655 polym ...... all cell lung cancer patients.

@en

Impact of HER2 codon 655 polym ...... all cell lung cancer patients.

@nl

type

Item

label

Impact of HER2 codon 655 polym ...... all cell lung cancer patients.

@en

Impact of HER2 codon 655 polym ...... all cell lung cancer patients.

@nl

prefLabel

Impact of HER2 codon 655 polym ...... all cell lung cancer patients.

@en

Impact of HER2 codon 655 polym ...... all cell lung cancer patients.

@nl

P1476

Impact of HER2 codon 655 polym ...... all cell lung cancer patients.

@en

P2093

Anastasiya Chokoeva

http://www.w3.org/2001/XMLSchema#string

Desislava Skerleva

http://www.w3.org/2001/XMLSchema#string

Elina Aleksandrova

http://www.w3.org/2001/XMLSchema#string

Georgi Tchernev

http://www.w3.org/2001/XMLSchema#string

Jelena Stojšić

http://www.w3.org/2001/XMLSchema#string

Julian Ananiev

http://www.w3.org/2001/XMLSchema#string

Maya Gulubova

http://www.w3.org/2001/XMLSchema#string

Milica Kontić

http://www.w3.org/2001/XMLSchema#string

P2860

Role of molecular studies in the diagnosis of lung adenocarcinoma

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells.

Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role? Focus on Eastern Cooperative Oncology Group study 2598.

Management of lung cancer

Investigation of HER-2 codon 655 single nucleotide polymorphism frequency and c-ErbB-2 protein expression alterations in gastric cancer patients

Targeting the EGFR signaling pathway in cancer therapy.

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.

Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival.

P2888

s10354-015-0366-5

P304

315-321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10354-015-0366-5

http://www.w3.org/2001/XMLSchema#string

P433

15-16

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P50

Uwe Wollina

Torello Lotti

P577

2015-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279777103

http://www.w3.org/2001/XMLSchema#string

P698

26208475

http://www.w3.org/2001/XMLSchema#string